Clinical Trials
15 trialsNCT03719768 2026-03-02
Avelumab With Radiotherapy in Patients With Leptomeningeal Disease
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT03520504 2022-12-23
Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT02423525 2022-03-10
Safety Study of Afatinib for Brain Cancer
Saint John's Cancer Institute
Phase 1 Completed
NCT02228369 2021-01-05
BLOOM
AstraZeneca
Phase 1 Completed
NCT03101579 2019-03-19
Intrathecal Pemetrexed for Recurrent Leptomeningeal Metastases From Non-small Cell Lung Cancer
The First Hospital of Jilin University
Phase 1 Completed
NCT00031928 2015-04-30
Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00416923 2015-02-16
Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma
University of California, San Francisco
Phase 1 Completed
NCT00854867 2014-02-24
Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.
Mundipharma Research Limited
Phase 1 Completed
NCT00002750 2013-02-20
Melphalan in Patients With Neoplastic Meningitis
Duke University
Phase 1 Completed
NCT00003020 2013-02-20
LMB-7 Immunotoxin in Treating Patients With Leptomeningeal Metastases
Duke University
Phase 1 Completed
NCT00003462 2013-02-20
Intrathecal Busulfan in Treating Patients With Recurrent, Refractory, or Metastatic Leptomeningeal Tumors
Duke University
Phase 1 Completed
NCT00005842 2013-02-11
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT00025311 2012-11-09
Topotecan in Treating Patients With Recurrent, Progressive, or Refractory Cancer That is Metastatic to the Lining Around the Brain
NYU Langone Health
Phase 1 Completed
NCT00674674 2012-05-15
PBTC-019
Baylor College of Medicine
Phase 1 Completed
NCT00006246 2009-10-07
Busulfan in Treating Children and Adolescents With Refractory CNS Cancer
Pediatric Brain Tumor Consortium
Phase 1 Completed